Biotech

All Articles

Turnstone lays off 60%, agitates C-suite to extend cash

.Turnstone Biologics is actually lessening its head count by 60% as well as agitating its C-suite so...

Gilead gives up on $15M MASH wager after reviewing preclinical records

.In a year that has observed an approval and a plethora of readouts for metabolic dysfunction-associ...

Texas biotech axes cancer pact, pins hopes on obesity

.Alaunos Therapies is actually axing a deal along with Precigen, quiting licensing civil liberties t...

Capricor portions even more information for DMD therapy after triggering BLA

.Capricor Therapeutics is actually taking a victory tour for their phase 2 Duchenne muscle dystrophy...

FDA places Kezar lupus test in hold observing 4 client fatalities

.The FDA has actually positioned Kezar Lifestyle Sciences' lupus trial on hold after the biotech fla...

Phase 3 Academic Rock test hits SMA objective, delivering stock up 200%

.A phase 3 test of Intellectual Rock's spinal muscle degeneration (SMA) prospect has actually hit it...

CAMP 4 is most up-to-date to eye IPO, while Upstream describe $182M program

.RNA biotech CAMP4 Therapeutics has defined prepare for a $67 thousand IPO, with inflammation-focuse...

Galecto buys leukemia drug, drops bone tissue cancer cells possession in pivot

.A year after the breakdown of an idiopathic lung fibrosis prospect delivered Galecto on a search fo...

Judo throws down $100M to knock out kidney disease

.Taking the mat is actually Judo Biography, a promising biotech armed along with $one hundred millio...

AstraZeneca pays out CSPC $100M for preclinical cardiovascular disease medication

.AstraZeneca has settled CSPC Pharmaceutical Group $one hundred million for a preclinical heart dise...